• 1. An intermolecular C–C coupling reaction of iridium complexes?
  Kathrin Kutlescha,Rhett Kempe New J. Chem., 2010,34, 1954-1960
• 2. An approach to the structure and vibrational analysis of cis- and trans-3-chlorostyrene through IR/Raman and INS spectroscopies and theoretical ab initio/DFT calculations?
  J. M. Granadino-Roldán,M. Fernández-Gómez,A. Navarro,T. Pe?a Ruiz,U. A. Jayasooriya Phys. Chem. Chem. Phys., 2004,6, 1133-1143
• 3. An investigation on the second-order nonlinear optical response of cationic bipyridine or phenanthroline iridium(iii) complexes bearing cyclometallated 2-phenylpyridines with a triphenylamine substituent?
  David B. Cordes,Alexandra M. Z. Slawin,Stefania Righetto,Denis Jacquemin,Eli Zysman-Colman,Véronique Guerchais Dalton Trans., 2018,47, 8292-8300
• 4. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 5. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Research Brief on 2-Amino-5-phenyl-5,6-dihydro-1,3-benzothiazol-7(4H)-one (CAS: 334506-28-4): Recent Advances and Applications

The compound 2-Amino-5-phenyl-5,6-dihydro-1,3-benzothiazol-7(4H)-one (CAS: 334506-28-4) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research brief aims to summarize the latest findings related to this compound, focusing on its synthesis, biological activities, and potential applications in drug development.

Recent studies have highlighted the versatility of 2-Amino-5-phenyl-5,6-dihydro-1,3-benzothiazol-7(4H)-one as a scaffold for designing novel bioactive molecules. Its benzothiazole core, combined with the amino and phenyl substituents, provides a robust platform for interactions with various biological targets. Researchers have explored its potential as an inhibitor of key enzymes involved in inflammatory and neurodegenerative pathways, making it a promising candidate for further drug development.

One of the most notable advancements in the study of this compound is its application in the synthesis of derivatives with enhanced pharmacological properties. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that modifications to the phenyl ring and the amino group could significantly improve the compound's bioavailability and target specificity. These derivatives exhibited potent activity against a range of biological targets, including kinases and G-protein-coupled receptors (GPCRs), which are critical in various disease pathways.

In addition to its therapeutic potential, 2-Amino-5-phenyl-5,6-dihydro-1,3-benzothiazol-7(4H)-one has also been investigated for its role in chemical biology. Its ability to act as a fluorescent probe has been leveraged in imaging studies to track cellular processes in real-time. This dual functionality—both as a therapeutic agent and a diagnostic tool—underscores its value in multidisciplinary research.

Despite these promising developments, challenges remain in optimizing the compound's pharmacokinetic and pharmacodynamic profiles. Current research is focused on addressing issues such as metabolic stability and tissue penetration. Collaborative efforts between academic institutions and pharmaceutical companies are underway to advance this compound into preclinical trials, with the goal of translating these findings into clinical applications.

In conclusion, 2-Amino-5-phenyl-5,6-dihydro-1,3-benzothiazol-7(4H)-one represents a compelling area of research in chemical biology and drug discovery. Its structural versatility and broad biological activity make it a valuable candidate for further exploration. Continued research into its derivatives and mechanisms of action will likely yield new insights and therapeutic opportunities in the coming years.

• 883195-16-2(Acetamide, N-(6-benzoyl-4,5,6,7-tetrahydro-7-oxo-2-benzothiazolyl)-)
• 1629-95-4(2-amino-5,5-dimethyl-4,5,6,7-tetrahydro-1,3-benzothiazol-7-one)
• 805250-54-8(2-Amino-5,6-dihydro-7(4H)-benzothiazolone Hydrobromide)
• 17583-10-7(2-amino-4,5,6,7-tetrahydro-1,3-benzothiazol-7-one)
• 109317-52-4(2-Amino-5,5-dimethyl-5,6-dihydro-4H-benzothiazol-7-one Hydrobromide)
• 375825-03-9(2-Amino-5-methyl-4,5,6-trihydrobenzothiazol-7-one)
• 343348-69-6(1-Propanone, 1-[2-amino-4-(1,1-dimethylethyl)-5-thiazolyl]-2,2-dimethyl-)
• 79932-21-1(6-Phenyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine)
• 87707-28-6(7(4H)-Benzothiazolone, 2-amino-5,6-dihydro-6,6-dimethyl-)
• 17583-11-8(7(4H)-Benzothiazolone, 5,6-dihydro-2-(methylamino)-)